174 related articles for article (PubMed ID: 10696248)
1. Mutation of cell cycle regulators and their impact on superficial bladder cancer.
Rabbani F; Cordon-Cardo C
Urol Clin North Am; 2000 Feb; 27(1):83-102, ix. PubMed ID: 10696248
[TBL] [Abstract][Full Text] [Related]
2. Genetic studies and molecular markers of bladder cancer.
Cordon-Cardo C; Sheinfeld J; Dalbagni G
Semin Surg Oncol; 1997; 13(5):319-27. PubMed ID: 9259087
[TBL] [Abstract][Full Text] [Related]
3. Alterations of tumor suppressor genes in bladder cancer.
Cordon-Cardo C; Reuter VE
Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice.
Dalbagni G; Cordon-Cardo C; Reuter V; Fair WR
Surg Oncol Clin N Am; 1995 Apr; 4(2):231-40. PubMed ID: 7796283
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer. I. Molecular and genetic basis of carcinogenesis.
Brandau S; Böhle A
Eur Urol; 2001 May; 39(5):491-7. PubMed ID: 11464028
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer.
Cordon-Cardo C; Wartinger D; Petrylak D; Dalbagni G; Fair WR; Fuks Z; Reuter VE
J Natl Cancer Inst; 1992 Aug; 84(16):1251-6. PubMed ID: 1640484
[TBL] [Abstract][Full Text] [Related]
7. Altered RB expression is a prognostic clinical marker involved in human bladder tumorigenesis.
Benedict WF
J Cell Biochem Suppl; 1992; 16I():69-71. PubMed ID: 1305691
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer.
Cordon-Cardo C; Sheinfeld J
World J Urol; 1997; 15(2):112-9. PubMed ID: 9144901
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
[TBL] [Abstract][Full Text] [Related]
10. Recessive oncogenes.
Bookstein R; Allred DC
Cancer; 1993 Feb; 71(3 Suppl):1179-86. PubMed ID: 8428341
[TBL] [Abstract][Full Text] [Related]
11. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
12. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma and p53 genes as prognostic indicators in urological oncology.
Wolff JM; Stephenson RN; Jakse G; Habib FK
Urol Int; 1994; 53(1):1-5. PubMed ID: 7974878
[TBL] [Abstract][Full Text] [Related]
14. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.
Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M]
J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499
[TBL] [Abstract][Full Text] [Related]
15. A molecular genetic model of human bladder cancer pathogenesis.
Reznikoff CA; Belair CD; Yeager TR; Savelieva E; Blelloch RH; Puthenveettil JA; Cuthill S
Semin Oncol; 1996 Oct; 23(5):571-84. PubMed ID: 8893868
[TBL] [Abstract][Full Text] [Related]
16. [Cell cycle, tumor suppressor genes and lung cancers].
Bréchot JM
Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
[TBL] [Abstract][Full Text] [Related]
17. Genetics of bladder cancer.
Saran KK; Gould D; Godec CJ; Verma RS
J Mol Med (Berl); 1996 Aug; 74(8):441-5. PubMed ID: 8872857
[TBL] [Abstract][Full Text] [Related]
18. Molecular prognostic factors in bladder cancer.
Vet JA; Debruyne FM; Schalken JA
World J Urol; 1994; 12(2):84-8. PubMed ID: 7916239
[TBL] [Abstract][Full Text] [Related]
19. Molecular alterations in bladder cancer.
Cordon-Cardo C
Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
[TBL] [Abstract][Full Text] [Related]
20. Allelic deletions of cell growth regulators during progression of bladder cancer.
Primdahl H; von der Maase H; Christensen M; Wolf H; Orntoft TF
Cancer Res; 2000 Dec; 60(23):6623-9. PubMed ID: 11118045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
